Tech Focus Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Asia.

Press releases published on August 7, 2026

Aug. 7, 2026

Second Annual Open Atlas Summit to Convene High-Skilled Immigrants, Founders, Investors and Students in Silicon Valley

Indeterminate EIN Presswire

Aug. 7, 2026

Pervaziv AI Debuts Cortex Router as the Eighth Model in Its Specialized AI Ensemble

Indeterminate EIN Presswire

Aug. 7, 2026

JRR Marketing Launches Course to Help Agencies Build Reporting Software With AI

Indeterminate EIN Presswire

Aug. 7, 2026

Global Uranium Corp. Announces 10:1 Share Consolidation

Indeterminate GlobeNewswire

Aug. 7, 2026

Beyond Encouragement: Momcozy Calls for Breastfeeding Support That Works in Real Life

Indeterminate EIN Presswire

Aug. 7, 2026

NevGold Announces Change of Auditor and Continuance to British Columbia

Indeterminate GlobeNewswire

Aug. 7, 2026

China Intramedullary Nails Manufacturers for Vietnam’s Long-Bone Fracture Treatment Market

Indeterminate EIN Presswire

Aug. 7, 2026

Newcore Gold Files Pre-Feasibility Study Technical Report for the Enchi Gold Project, Ghana

Indeterminate GlobeNewswire

Aug. 7, 2026

AI/R lança plataforma unificada para governança de IA corporativa

Indeterminate GlobeNewswire

Aug. 7, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Atico Announces 2026 AGM Voting Results and Stepdown of Michael Winn as Director

Indeterminate GlobeNewswire

Aug. 7, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Aug. 7, 2026

Entera Announces Second Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Aug. 7, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

Braveheart Bio Announces Closing of Upsized Initial Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

Aug. 7, 2026

Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference

Indeterminate GlobeNewswire

Aug. 7, 2026

aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Indeterminate GlobeNewswire

Aug. 7, 2026

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Aug. 7, 2026

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Indeterminate GlobeNewswire

Aug. 7, 2026

Terra Balcanica Announces Extension to Private Placement Financing

Indeterminate GlobeNewswire